Next-Gen Surgical Support for Cardiac Procedures
KAI Membrane from CardioXtek is purpose-built for cardiac applications, uniquely designed to mitigate postoperative complications and enhance cardiac surgical outcomes. Developed with rigorous research and backed by robust clinical evidence, our advanced amniotic membrane offers unprecedented benefits specifically tailored for cardiac clinicians and surgeons.
Reduction in POAF
Membranes Delivered
Used in Hospitals
Clinically Proven Benefits:
KAI Membrane delivers significant improvements in cardiac healing, reducing POAF, infections, and inflammation while preserving heart function post-surgery.
Significant Reduction in Postoperative Atrial Fibrillation (POAF)
Significant Reduction in Postoperative Atrial Fibrillation (POAF).
Directly addresses ischemia reperfusion injury, significantly lowering inflammation and oxidative stress after coronary artery bypass grafting (CABG).
Scar Remodeling and Enhanced Cardiac Function
Unique regenerative properties stimulate remodeling of cardiac scar tissue, preserving cardiac function and reducing reliance on mechanical support or transplants.
Demonstrated improvements in cardiac function across human and animal models, including enhanced ejection fraction and reduced infarct size.
Accelerated Healing and Reduced Infection Risk
Innovative application methods—patches, injectables, and extracellular matrix forms—accelerate wound healing and significantly reduce surgical site infections.
Dr. Khalpey's clinical application showed a remarkable reduction in wound complications, infections, and dehiscence rates, ensuring faster recovery and improved patient comfort.
Rigorous Cardiac-Focused Research
Our approach is differentiated by a clear cardiac specialty focus:
Extensive research collaboration with leading cardiac experts, validated in multiple rigorous trials.
Specialized exploration of mechanisms such as anti-inflammatory, anti-fibrotic, and pro-angiogenic effects.
Ongoing studies evaluating advanced uses, including direct myocardial injections and robotically assisted atrial fibrillation ablation procedures.
Safety and Regulatory Commitment
Proven safety profile: zero infections related to KAI Membrane use.
The CardioXtek Difference
KAI Membrane’s targeted cardiac research and specialized applications distinctly separate it from general-purpose regenerative products:
Specifically designed and researched for cardiac surgical contexts.
Strong, tangible clinical outcomes demonstrating significant cost savings and improved patient outcomes.
Backed by leading cardiac surgeons and validated through high-quality evidence.
Key Discussion Points:
Explore Clinical Integration with KAI Membrane
Contact us today to discuss clinical integration, research opportunities, or to schedule a personalized presentation on how KAI Membrane can enhance your surgical outcomes and patient care quality.